Martin Shkreli

Claude AI, developed by Anthropic, autonomously designed 1,320 protein binders, of which 354 were lab-validated, achieving a 26.8% average hit rate across 14 of 15 targets, according to Adaptyv Bio. T…

Martin Shkreli, the convicted former pharmaceutical executive, has offered commentary on AI safety that, while containing some technically accurate points, is met with skepticism due to his history of…

Leopold Aschenbrenner's AI-focused hedge fund, Situational Awareness, was forced to sell most of its publicly traded stock portfolio to Citadel after steep losses on AI positions, with the fund once s…